Total Payments
$29,383
2024 Payments
$921.51
Companies
48
Transactions
461
Medicare Patients
12,507
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$19,710 (67.1%)
Food & Beverage$8,155 (27.8%)
Travel$1,508 (5.1%)
Education$10.53 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,710 | 28 | 67.1% |
| Food and Beverage | $8,155 | 426 | 27.8% |
| Travel and Lodging | $1,508 | 6 | 5.1% |
| Education | $10.53 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $20,838 | 88 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,694 | 16 | $0 (2019) |
| Biosense Webster, Inc. | $1,031 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $692.33 | 43 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $674.89 | 45 | $0 (2024) |
| Amgen Inc. | $600.21 | 35 | $0 (2023) |
| PFIZER INC. | $583.42 | 48 | $0 (2024) |
| Boston Scientific Corporation | $453.85 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $285.10 | 20 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $268.22 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $921.51 | 42 | Biosense Webster, Inc. ($235.96) |
| 2023 | $1,237 | 60 | Medtronic, Inc. ($223.81) |
| 2022 | $1,429 | 46 | Biosense Webster, Inc. ($600.00) |
| 2021 | $1,064 | 53 | Abbott Laboratories ($484.22) |
| 2020 | $5,010 | 48 | Abbott Laboratories ($4,450) |
| 2019 | $2,840 | 69 | Medtronic Vascular, Inc. ($1,536) |
| 2018 | $4,767 | 69 | Abbott Laboratories ($3,774) |
| 2017 | $12,115 | 74 | Abbott Laboratories ($11,384) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Cardiovascular | ||||||
| 12/06/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/05/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.23 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/20/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 08/14/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 08/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.47 | General |
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: DIABETES | ||||||
| 06/22/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | Biosense Webster, Inc. | QDOT MICRO Catheter (Device) | Food and Beverage | In-kind items and services | $30.71 | General |
| 05/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,202 | 5,092 | $1.1M | $346,576 |
| 2022 | 31 | 2,955 | 4,866 | $942,880 | $317,267 |
| 2021 | 38 | 3,139 | 5,044 | $917,804 | $331,259 |
| 2020 | 39 | 3,211 | 4,974 | $879,024 | $308,326 |
Total Patients
12,507
Total Services
19,976
Medicare Billing
$1.3M
Procedure Codes
145
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 743 | 928 | $190,534 | $82,520 | 43.3% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 80 | 80 | $224,920 | $57,311 | 25.5% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 48 | 48 | $89,007 | $27,898 | 31.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 56 | 56 | $74,108 | $21,627 | 29.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 449 | 957 | $77,602 | $19,383 | 25.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 548 | 1,226 | $71,752 | $18,246 | 25.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 267 | 305 | $40,417 | $17,143 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $30,831 | $14,357 | 46.6% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 51 | 62 | $65,095 | $14,280 | 21.9% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 38 | 60 | $63,062 | $13,904 | 22.0% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 14 | 14 | $32,562 | $9,611 | 29.5% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 30 | 30 | $26,891 | $7,477 | 27.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 113 | 223 | $36,124 | $5,718 | 15.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 92 | $10,827 | $5,567 | 51.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $13,094 | $5,307 | 40.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 43 | $9,554 | $4,254 | 44.5% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 42 | 50 | $10,104 | $3,674 | 36.4% |
| 33207 | Insertion of pacemaker and lower heart chamber electrode | Facility | 2023 | 11 | 11 | $13,255 | $2,883 | 21.8% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 33 | 38 | $6,943 | $2,426 | 34.9% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 38 | 38 | $14,013 | $2,339 | 16.7% |
| 93641 | Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | Facility | 2023 | 16 | 16 | $13,192 | $1,857 | 14.1% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 25 | 29 | $4,397 | $1,826 | 41.5% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 20 | 22 | $2,441 | $1,099 | 45.0% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2023 | 18 | 110 | $1,980 | $726.84 | 36.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 75 | 77 | $7,928 | $724.28 | 9.1% |
About David Wang
David Wang is a Cardiovascular Disease healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649491440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Wang has received a total of $29,383 in payments from pharmaceutical and medical device companies, with $921.51 received in 2024. These payments were reported across 461 transactions from 48 companies. The most common payment nature is "Consulting Fee" ($19,710).
As a Medicare-enrolled provider, Wang has provided services to 12,507 Medicare beneficiaries, totaling 19,976 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Provo, UT
- Active Since 05/01/2007
- Last Updated 11/27/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1649491440
Products in Payments
- Pacemakers (Device) $5,460
- Fortify Assura, Ellipse ICD (Device) $4,300
- Allure Quadra RF CRT Pacemaker (Device) $3,744
- ICDs (Device) $3,120
- ICD Leads (Device) $2,496
- Arctic Front (Device) $1,553
- XARELTO (Drug) $674.89
- JARDIANCE (Drug) $510.99
- Repatha (Biological) $470.67
- ELIQUIS (Drug) $469.96
- WATCHMAN (Device) $384.42
- Accent Pacemaker (Device) $266.05
- ENTRESTO (Drug) $238.82
- AVEIR (Device) $202.24
- Sotalol Hydrochloride (Drug) $194.39
- Confirm Rx (Device) $192.83
- PRADAXA (Drug) $181.34
- CRT-Ds (Device) $175.81
- UPTRAVI (Drug) $175.78
- QDOT MICRO Catheter (Device) $170.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Provo
Chun Hwang, Md, MD
Cardiovascular Disease — Payments: $237,970
Cardiovascular Disease $237,970
James Feeney, Md Facc, MD FACC
Cardiovascular Disease — Payments: $23,240
Cardiovascular Disease $23,240
Marvin Allen, Md, MD
Cardiovascular Disease — Payments: $13,582
Cardiovascular Disease $13,582
Daniel Bennett, Md, MD
Cardiovascular Disease — Payments: $13,400
Cardiovascular Disease $13,400
Stephen Wilkinson, Md, MD
Cardiovascular Disease — Payments: $8,436
Cardiovascular Disease $8,436
Brennan Rigby, Md, MD
Cardiovascular Disease — Payments: $7,848
Cardiovascular Disease $7,848